04/10/2024
3:03 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:47 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:49 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:05 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:06 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
8:21 PM | Agios Pharmaceuticals (Subject)
Schenkein David P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/22/2024
4:43 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
9:33 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:50 PM | Agios Pharmaceuticals (Issuer)
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:21 PM | Agios Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:07 AM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SC 13G/A | |
02/12/2024
10:21 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/12/2024
9:50 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/08/2024
10:39 AM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
3:20 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:23 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:24 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
11:37 AM | Agios Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:26 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:28 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:58 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:10 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
4:18 PM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
11/09/2023
12:26 PM | Agios Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/02/2023
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:02 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:04 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:38 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
3:02 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:07 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:09 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:37 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Agios Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Now Open: Crypto emergency update (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
06/23/2023
3:34 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:36 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:30 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:32 PM | Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:22 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:23 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:25 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:26 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:13 PM | Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/15/2023
3:17 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2023
3:13 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/04/2023
8:55 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2023
6:26 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
